Subtopic Deep Dive
Myostatin Regulation
Research Guide
What is Myostatin Regulation?
Myostatin regulation encompasses molecular mechanisms inhibiting myostatin, a TGF-β superfamily member that limits skeletal muscle growth, and strategies to block it for inducing hypertrophy.
Myostatin acts as a negative regulator of muscle mass via activin receptor signaling. Follistatin binds and neutralizes myostatin to promote muscle growth (Lee et al., 2010, 260 citations). Genetic mutations or pharmacological antagonists enhance muscle mass in models of atrophy.
Why It Matters
Myostatin inhibition counters muscle wasting in sarcopenia, cachexia, and Duchenne muscular dystrophy, offering therapies for aging-related frailty (Damluji et al., 2023, 482 citations; Wiedmer et al., 2020, 405 citations). Follistatin overexpression increases muscle mass in vivo, supporting applications in livestock breeding and human hypertrophy treatments (Lee et al., 2010). Antagonists improve outcomes in cancer cachexia models by preserving skeletal muscle (Peixoto da Silva et al., 2020, 341 citations).
Key Research Challenges
Specificity of inhibitors
Myostatin inhibitors like follistatin also bind activins, causing off-target effects on non-muscle tissues (Lee et al., 2010). Developing selective antagonists remains difficult due to shared TGF-β receptors. Clinical translation faces safety hurdles from broad signaling disruption.
Translating to humans
Genetic models show robust hypertrophy, but human trials reveal limited efficacy due to species differences (Duan et al., 2021, 1154 citations). Pharmacokinetic challenges limit sustained inhibition. Combining with exercise yields inconsistent results in sarcopenia (Damluji et al., 2023).
Atrophy pathway integration
Myostatin interacts with inflammation and FoxO pathways in cachexia, complicating isolated targeting (Webster et al., 2020, 305 citations; Lee and Goldberg, 2013, 204 citations). MicroRNAs like miR-29b regulate multiple atrophy types beyond myostatin (Li et al., 2017, 240 citations). Holistic pathway mapping is needed.
Essential Papers
Duchenne muscular dystrophy
Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda et al. · 2021 · Nature Reviews Disease Primers · 1.2K citations
Sarcopenia and Cardiovascular Diseases
Abdulla A. Damluji, Maha Alfaraidhy, Noora Alhajri et al. · 2023 · Circulation · 482 citations
Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia ...
Sarcopenia – Molecular mechanisms and open questions
Petra Wiedmer, Tobias Jung, José Pedro Castro et al. · 2020 · Ageing Research Reviews · 405 citations
Sarcopenia represents a muscle-wasting syndrome characterized by progressive and generalized degenerative loss of skeletal muscle mass, quality, and strength occurring during normal aging. Sarcopen...
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Sara Peixoto da Silva, Joana Santos, Maria Paula Costa e Silva et al. · 2020 · Journal of Cachexia Sarcopenia and Muscle · 341 citations
Abstract Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic abnor...
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine Webster, Laura JAP Kempen, Rowan Hardy et al. · 2020 · Frontiers in Physiology · 305 citations
Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no specific ...
Cancer Cachexia: Mechanisms and Clinical Implications
Claire L. Donohoe, Aoife M. Ryan, John V. Reynolds · 2011 · Gastroenterology Research and Practice · 269 citations
Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting in progressive weight loss. It is associated with poor quality of life, poor physical function, and poor...
Regulation of Muscle Mass by Follistatin and Activins
Se‐Jin Lee, Yun‐Sil Lee, Teresa A. Zimmers et al. · 2010 · Molecular Endocrinology · 260 citations
Myostatin is a TGF-β family member that normally acts to limit skeletal muscle mass. Follistatin is a myostatin-binding protein that can inhibit myostatin activity in vitro and promote muscle growt...
Reading Guide
Foundational Papers
Start with Lee et al. (2010) for core myostatin-follistatin mechanisms and muscle growth models; Lee and Goldberg (2013) for SIRT1-FoxO atrophy links; Smith and Barton (2014) for quantitative histology tools.
Recent Advances
Damluji et al. (2023) on sarcopenia therapies; Wiedmer et al. (2020) for molecular mechanisms; Li et al. (2017) on miR-29b in atrophy.
Core Methods
Follistatin binding assays, activin receptor kinase inhibition, SMASH semi-automated fiber analysis (Smith and Barton, 2014), SIRT1 deacetylation of FoxO (Lee and Goldberg, 2013).
How PapersFlow Helps You Research Myostatin Regulation
Discover & Search
Research Agent uses searchPapers and citationGraph to map myostatin-follistatin interactions from Lee et al. (2010), revealing 260 citing papers on inhibitors. exaSearch finds pharmacological antagonists; findSimilarPapers expands to sarcopenia applications (Damluji et al., 2023).
Analyze & Verify
Analysis Agent applies readPaperContent to parse Lee et al. (2010) for follistatin mechanisms, then verifyResponse with CoVe checks claims against 50+ citations. runPythonAnalysis quantifies muscle fiber data from Smith and Barton (2014) histology; GRADE grades evidence for clinical translation in Duan et al. (2021).
Synthesize & Write
Synthesis Agent detects gaps in human myostatin trials via contradiction flagging across cachexia papers (Peixoto da Silva et al., 2020). Writing Agent uses latexEditText, latexSyncCitations, and latexCompile for hypertrophy pathway reviews; exportMermaid diagrams TGF-β signaling networks.
Use Cases
"Analyze muscle fiber size data from myostatin inhibition histology images."
Analysis Agent → readPaperContent (Smith and Barton, 2014) → runPythonAnalysis (SMASH MATLAB stats on fiber CSA, pandas histograms) → matplotlib plots of hypertrophy metrics.
"Write a review on follistatin for sarcopenia therapy with citations."
Synthesis Agent → gap detection (Lee et al., 2010 + Damluji et al., 2023) → Writing Agent → latexEditText (draft), latexSyncCitations (250 refs), latexCompile (PDF) → exportBibtex.
"Find code for myostatin signaling simulations or muscle analysis."
Research Agent → paperExtractUrls (Smith and Barton, 2014) → Code Discovery → paperFindGithubRepo (SMASH MATLAB) → githubRepoInspect (segmentation scripts) → runPythonAnalysis (adapt for new data).
Automated Workflows
Deep Research workflow scans 50+ papers on myostatin via searchPapers → citationGraph (Lee et al., 2010 hub) → structured report on inhibitors for cachexia. DeepScan applies 7-step CoVe to verify follistatin efficacy claims (Wiedmer et al., 2020). Theorizer generates hypotheses on miR-29b-myostatin links from Li et al. (2017).
Frequently Asked Questions
What is myostatin regulation?
Myostatin regulation involves inhibiting a TGF-β ligand that suppresses muscle growth, primarily via follistatin binding or genetic knockout (Lee et al., 2010).
What are key methods for studying it?
Methods include follistatin overexpression in mice, histology segmentation with SMASH (Smith and Barton, 2014), and analysis of activin receptor signaling.
What are landmark papers?
Lee et al. (2010, 260 citations) defines follistatin-myostatin axis; Duan et al. (2021, 1154 citations) links to dystrophy therapies.
What open problems exist?
Selective inhibitors avoiding activin effects, human efficacy beyond models, and integration with inflammation pathways (Webster et al., 2020).
Research Muscle Physiology and Disorders with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Myostatin Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Muscle Physiology and Disorders Research Guide